Related Experiment Video
Updated: Jan 12, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Antibody Levels Against Mumps Virus in Children After Implementation of the Two-Dose MMR Vaccine Policy - Fujian
Zhifei Chen1,2, Rui Chen2, Ruihong Wu1,2
1Fujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fuzhou City, Fujian Province, China.
What Is Already Known About This Topic?:
The Measles-Mumps-Rubella (MMR) vaccine plays a crucial role in preventing mumps. Before the implementation of the two-dose MMR vaccine policy, baseline data on mumps virus antibody seroprevalence and geometric mean concentrations (GMCs) among children and adolescents in Fujian Province were available.
What Is Added By This Report?:
This report provides a post-policy evaluation following the introduction of Fujian's two-dose MMR policy in June 2020. The 2023 survey shows an overall seroprevalence of 79.53% and a GMC of 265.61 U/mL. Compared with 2018, significant improvements were observed in children under 2 years; however, a concerning decline was noted among adolescents aged 15-17 years. Antibody levels peaked shortly after vaccination, and two doses were found to confer significantly higher immunity than one dose within a 270-day period.
What Are The Implications For Public Health Practices?:
The two-dose MMR policy has been effective in improving early childhood immunity. However, the observed waning immunity in adolescents underscores the urgent need for ongoing serological surveillance, particularly in individuals aged 6-19 years, to inform potential recommendations for booster vaccinations.
Insights
The two-dose Measles-Mumps-Rubella (MMR) vaccine policy improved immunity in young children in Fujian Province. However, waning immunity in adolescents necessitates ongoing surveillance for potential booster vaccinations.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- The Measles-Mumps-Rubella (MMR) vaccine is vital for mumps prevention.
- Baseline mumps virus antibody seroprevalence and geometric mean concentrations (GMCs) data existed before the two-dose policy in Fujian Province.
Purpose of the Study:
- To evaluate the effectiveness of Fujian's two-dose MMR policy implemented in June 2020.
- To assess mumps virus antibody seroprevalence and GMCs post-policy implementation.
Main Methods:
- A 2023 serological survey was conducted in Fujian Province.
- Data analysis compared post-policy results with pre-policy baseline data from 2018.
Main Results:
- Overall seroprevalence was 79.53% with a GMC of 265.61 U/mL in 2023.
- Significant immunity improvements were seen in children under 2 years.
- A decline in antibody levels was observed in adolescents aged 15-17 years.
- Two MMR doses provided higher immunity than one dose within 270 days.
Conclusions:
- The two-dose MMR policy effectively enhanced early childhood immunity.
- Waning immunity in adolescents highlights the need for continued serological surveillance.
- Recommendations for booster vaccinations may be needed for individuals aged 6-19 years.
More Related Videos
08:48Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
12:09Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Cross-reactivity